Skip to main content

Moors & Cabot, Inc.

Position in MRK — Merck & Co., Inc.

CIK 1607239 BOSTON, MA

Position in MRK

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$12,164,452
+$607,230 QoQ
Shares Held
94,665
-1.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#675
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MRK Over Time

Shares Held

Position Value (USD)

Derivatives in MRK

reported options exposure · as of Mar 31, 2022
CallValue
$4,000
CallShares
800
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Moors & Cabot, Inc. holds $115,416,483 across 14 Drug Manufacturers - General names. MRK ranks #4 (10.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 MRK
Merck & Co., Inc.
This page
94,665 $12,164,452

All Filings in MRK

Export CSV
29 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,164,452 94,665
2026-03-31 $11,557,222 96,078
2025-12-31 $10,312,532 97,972
2025-09-30 $7,742,206 92,246
2025-06-30 $8,878,031 112,153
2025-03-31 $11,800,477 131,467
2024-12-31 $14,316,863 143,917
2024-09-30 $16,397,382 144,394
2024-06-30 $17,983,311 145,261
2024-03-31 $19,024,287 144,178
2023-12-31 $15,485,963 142,047
2023-09-30 $14,749,440 143,268
2023-06-30 $16,862,979 146,139
2023-03-31 $15,659,331 147,188
2022-12-31 $16,740,912 150,887
2022-09-30 $12,702,441 147,497
2022-06-30 $13,718,076 150,467
2022-03-31 $11,932,285 145,427
2022-03-31 $4,000 800
2021-12-31 $10,107,513 131,883
2021-09-30 $9,732,453 129,576
2021-09-30 $2,000 2,500
2021-06-30 $9,121,565 117,289
2021-03-31 $9,047,364 117,361
2020-12-31 $9,796,036 119,756
2020-09-30 $9,943,718 119,876
2020-09-30 $1,000 200
2020-06-30 $9,351,675 120,932
2020-03-31 $8,822,244 114,664